title: Novel mechanical assistance in the treatment of endotoxic and septicemic shock.
abstract: Systemic sepsis is a frequent and fatal complication of postoperative patients. More recently, therapeutic trials of plasma or blood exchange are performed in septic patients for the purpose of reducing both endotoxins and albumin-bound toxins. As an alternate approach such as this for the removal of endotoxin directly from the blood, the authors recently developed polymyxin B immobilized fiber (PMX-F) as a biomaterial for selectively detoxifying endotoxin. That this newly invented PMX-F neutralizes a sufficient amount of endotoxin in vitro was reported previously. In ex vivo experiments, direct hemoperfusion by PMX-F was performed on purified endotoxin injected canine and on live Escherichia coli induced septic dogs. Only 5% (1/20) survived in the control group, but 75% (30/40) survived in the treated group. Septic dogs died within 18 hours after bacteria infusion in the control group. But all in the treated group survived 3 days. Forty percent of them survived permanently. These observations indicate that PMX-F treatment, namely selective removal of endotoxin in the endotoxic and septicaemic dogs prolongs or increases the chances of survival. Blood compatibility of PMX-F was also evaluated both in vitro and in vivo. With platelets it was shown to be fairly good and with red blood cells, white blood cells, and proteins, extremely good. A preclinical study on the efficacy and safety of PMX-F throughout widespread experiments has just ended.
authors.affiliation: First Department of Surgery, Shiga University of Medical Science, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Hanasawa
authors.forename: H
authors.initials: H
authors.lastname: Aoki
authors.forename: T
authors.initials: T
authors.lastname: Yoshioka
authors.forename: K
authors.initials: K
authors.lastname: Matsuda
authors.forename: T
authors.initials: T
authors.lastname: Tani
authors.forename: M
authors.initials: M
authors.lastname: Kodama
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D004285:Dogs; D004927:Escherichia coli Infections / Q000628:therapy; D006464:Hemoperfusion / Q000295:instrumentation*; D007773:Lactates / Q000097:blood; D019344:Lactic Acid; D009102:Multiple Organ Failure / Q000628:therapy*; D010951:Plasma Exchange / Q000295:instrumentation*; D011112:Polymyxin B / Q000008:administration & dosage*; D011113:Polymyxins / Q000008:administration & dosage*; D011137:Polystyrenes; D012772:Shock, Septic / Q000097:blood / Q000628:therapy*
chemical_list: D001786:Blood Glucose; D007773:Lactates; D011113:Polymyxins; D011137:Polystyrenes; D019344:Lactic Acid; D011112:Polymyxin B